Revised SPCs: Revlimid (lenalidomide) Hard Capsules

The SPC has been updated to note cases of pulmonary hypertension, some fatal, have been reported in patients treated with lenalidomide. Patients should be evaluated for signs and symptoms of underlying cardiopulmonary disease prior to initiating and during lenalidomide therapy.

Source:

electronic Medicines compendium